Corporate Compliance

Pharma executives banned from federal healthcare programs

Compliance Monitor, January 28, 2009

An administrative law judge stripped three former Purdue Frederick executives of their participation privileges in all federal healthcare programs for the next 15 years. The decision affirms exclusions that the Office of Inspector General (OIG) previously imposed on the men, whose former company manufactures and distributes OxyContin.
 
According to an OIG press release issued January 23, Michael Friedman, chief operating officer and former CEO, Paul Goldenheim, MD, chief scientific officer, and Howard Udell, general counsel, all pleaded guilty in 2007 to misdemeanor misbranding of OxyContin. Purdue Frederick also pleaded guilty to felony misbranding of OxyContin, and has been banned from federal healthcare programs for 25 years. That exclusion is part of a global resolution between the US, Purdue Frederick, and Purdue Pharma, a related company. The resolution also includes a restitution fine of $600 million for both companies.

Comments

0 comments on “Pharma executives banned from federal healthcare programs

 

Most Popular